1-10 of 10
Ramón Alemany
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial

Xavier Garcia-del-Muro, Begoña P. Valderrama, Ana Medina-Colmenero, Olatz Etxaniz, Regina Gironés Sarrió, María José Juan-Fita, Marcel Costa-García, Rafael Moreno, Isabel Miras Rodríguez, Irene Ortiz, Andrés Cuéllar, Ferran Ferrer, Francesc Vigués, Roberto de Haro Piedra, Arturo Candal Gomez, Salvador Villà, José Luis Pontones, Yasmina Murria, Guillermo Lendínez-Cano, Ramon Alemany
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (4): 659–666.
https://doi.org/10.1158/1078-0432.CCR-24-2636
Published: 17 February 2025
View articletitled, Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial
Open the PDF for Bladder Preservation with Durvalumab plus Tremelimumab and Concurrent Radiotherapy in Patients with Localized Muscle-Invasive Bladder Cancer (IMMUNOPRESERVE): A Phase II Spanish Oncology GenitoUrinary Group Trial in another window
Includes: Supplementary data
Journal Articles

Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus

Martí Farrera-Sal, Laura Moya-Borrego, Miriam Bazan-Peregrino, Ramon Alemany
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (11): 2979–2988.
https://doi.org/10.1158/1078-0432.CCR-20-1565
Published: 01 June 2021
View articletitled, Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus
Open the PDF for Evolving Status of Clinical Immunotherapy with Oncolytic Adenovirus in another window
Journal Articles

Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma

Juri Kiyokawa, Yoichiro Kawamura, Shanawaz M. Ghouse, Simge Acar, Erinç Barçın, Jordi Martínez-Quintanilla, Robert L. Martuza, Ramon Alemany, Samuel D. Rabkin, Khalid Shah, Hiroaki Wakimoto
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3): 889–902.
https://doi.org/10.1158/1078-0432.CCR-20-2400
Published: 01 February 2021
View articletitled, Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma
Open the PDF for Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma in another window
Includes: Supplementary data
Journal Articles

Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus

Emma Eriksson, Ioanna Milenova, Jessica Wenthe, Magnus Ståhle, Justyna Leja-Jarblad, Gustav Ullenhag, Anna Dimberg, Raphael Moreno, Ramon Alemany, Angelica Loskog
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (19): 5846–5857.
https://doi.org/10.1158/1078-0432.CCR-17-0285
Published: 01 October 2017
View articletitled, Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus
Open the PDF for Shaping the Tumor Stroma and Sparking Immune Activation by CD40 and 4-1BB Signaling Induced by an Armed Oncolytic Virus in another window
Includes: Supplementary data
Journal Articles

The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma

Naiara Martínez-Vélez, Enric Xipell, Beatriz Vera, Arlet Acanda de la Rocha, Marta Zalacain, Lucía Marrodán, Marisol Gonzalez-Huarriz, Gemma Toledo, Manel Cascallo, Ramón Alemany, Ana Patiño, Marta M. Alonso
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (9): 2217–2225.
https://doi.org/10.1158/1078-0432.CCR-15-1899
Published: 01 May 2016
View articletitled, The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma
Open the PDF for The Oncolytic Adenovirus VCN-01 as Therapeutic Approach Against Pediatric Osteosarcoma in another window
Includes: Supplementary data
Journal Articles

Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression

Alba Rodríguez-García, Marta Giménez-Alejandre, Juan J. Rojas, Rafael Moreno, Miriam Bazan-Peregrino, Manel Cascalló, Ramon Alemany
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1406–1418.
https://doi.org/10.1158/1078-0432.CCR-14-2213
Published: 12 March 2015
View articletitled, Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression
Open the PDF for Safety and Efficacy of VCN-01, an Oncolytic Adenovirus Combining Fiber HSG-Binding Domain Replacement with RGD and Hyaluronidase Expression in another window
Includes: Supplementary data
Journal Articles

Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors

Petri Nokisalmi, Sari Pesonen, Sophie Escutenaire, Merja Särkioja, Mari Raki, Vincenzo Cerullo, Leena Laasonen, Ramon Alemany, Juan Rojas, Manel Cascallo, Kilian Guse, Maria Rajecki, Lotta Kangasniemi, Elina Haavisto, Aila Karioja-Kallio, Päivi Hannuksela, Minna Oksanen, Anna Kanerva, Timo Joensuu, Laura Ahtiainen, Akseli Hemminki
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (11): 3035–3043.
https://doi.org/10.1158/1078-0432.CCR-09-3167
Published: 31 May 2010
View articletitled, Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
Open the PDF for Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan

Candelaria Gomez-Manzano, Marta M. Alonso, W.K. Alfred Yung, Frank McCormick, David T. Curiel, Frederick F. Lang, Hong Jiang, B. Nebiyou Bekele, Xian Zhou, Ramon Alemany, Juan Fueyo
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (2): 556–562.
https://doi.org/10.1158/1078-0432.CCR-05-1892
Published: 20 January 2006
View articletitled, Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan
Open the PDF for Delta-24 Increases the Expression and Activity of Topoisomerase I and Enhances the Antiglioma Effect of Irinotecan in another window
Journal Articles

Conditionally Replicative Adenovirus with Tropism Expanded towards Integrins Inhibits Osteosarcoma Tumor Growth in Vitro and in Vivo

Adhiambo M. Witlox, Victor W. van Beusechem, Bonnie Molenaar, Hans Bras, Gerard R. Schaap, Ramon Alemany, David T. Curiel, Herbert M. Pinedo, Paul I. J. M. Wuisman, Winald R. Gerritsen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (1): 61–67.
https://doi.org/10.1158/1078-0432.CCR-0609-03
Published: 20 January 2004
View articletitled, Conditionally Replicative Adenovirus with Tropism Expanded towards Integrins Inhibits Osteosarcoma Tumor Growth in Vitro and in Vivo
Open the PDF for Conditionally Replicative Adenovirus with Tropism Expanded towards Integrins Inhibits Osteosarcoma Tumor Growth in Vitro and in Vivo in another window
Journal Articles

A Conditionally Replicative Adenovirus with Enhanced Infectivity Shows Improved Oncolytic Potency

Kaori Suzuki, Juan Fueyo, Victor Krasnykh, Paul N. Reynolds, David T. Curiel, Ramon Alemany
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (1): 120–126.
Published: 01 January 2001
View articletitled, A Conditionally Replicative Adenovirus with Enhanced Infectivity Shows Improved Oncolytic Potency
Open the PDF for A Conditionally Replicative Adenovirus with Enhanced Infectivity Shows Improved Oncolytic Potency in another window